Healthcare Organizations Call for Quick Action on Kickback Law Changes
...
From - Lab Compliance Advisor
After a recent dip, OIG enforcement activity has seemingly rebounded, at least in terms of total recoveries. That's the…
From - G2 Compliance Advisor
Just five years ago, Theranos was a Silicon Valley sensation with a valuation of over $9 billion. While black turtlenecked Elizabeth Holmes supplied the charisma, the heart of the Theranos phenomenon was…
From - G2 Compliance Advisor
Four years ago, Theranos was a $10 billion company poised to turn a breakthrough blood testing technology into a diagnostics dynamo to the tune of…
Recent report examining 10,000 claims to understand the key drivers of medical malpractice suits found 52 percent involved lab-related errors.
From - G2 Compliance Advisor
Before the opioid crackdown, false billing of genetic tests was the hottest thing in federal fraud enforcement against clinical labs. But while drug testing related to…